Jalen Hurts and the Philadelphia Eagles are favored to beat the Los Angeles Chargers, but our model has L.A. covering the spread. Cooper Neill / Getty Images Week 14 of NFL action has teams in ...

The NFL Week 14 schedule is full of intrigue, including several with playoff implications. Among them is the NFC North-leading Chicago Bears (9-3), who have won five in a row, visiting the 8-3-1 Green ...

The Denver Broncos aren't expecting an easier time in NFL Week 14 when they visit their AFC West rivals, the Las Vegas Raiders. The Broncos (10-2) have won nine in a row but have had some close ones, ...

Investing.com -- Fulcrum Therapeutics (NASDAQ:FULC) stock surged 50% Monday after the company reported positive initial results from its Phase 1b PIONEER trial of pociredir in sickle cell disease ...

Five weeks still remain on the NFL regular seasons schedule, but it could be Week 14 that is looked back upon as a turning point in a handful of key playoff races. Here’s a complete look at the NFL ...

Investing.com - Truist Securities raised its price target on Fulcrum Therapeutics (NASDAQ:FULC) to $18.00 from $14.00 on Thursday, while maintaining a Buy rating on the stock. The new target ...

There’s a strong case to be made that no slate of items has made a bigger impact on how distinguished men smell than the best Tom Ford colognes. The brand's seductive potions are admittedly not cheap, ...

CAMBRIDGE - Beam Therapeutics Inc. (NASDAQ:BEAM) released updated clinical data from 31 patients treated with its experimental sickle cell disease (SCD) gene therapy, showing sustained benefits ...

NORTHAMPTON, MA / ACCESS Newswire / December 12, 2025 / Originally published on Aflac Newsroom Brittany Smith, before she became an Aflac agent in 2024, embarked on a personal mission to support ...

Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the ...